Cao J, Hu D, Yu H, Xie Y, et al. Interleukin-2-inducible T-cell kinase inhibition to block NF-kappaB signaling exerts anti-tumor effect and enhances chemotherapy in NK/T-cell lymphoma. Cancer Lett 2025 Mar 5:217602. doi: 10.1016/j.canlet.2025.217602.
PMID: 40054659